Loading...
Loading...
Among the 7 tracked institutional investors we monitor, CYTK (CYTOKINETICS INC) is held with a combined value of $3.11B across 47,606,694 shares. The largest holder is BlackRock, Inc. with a position worth $1.09B (0.02% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$3.11B
Total Shares Held
47,606,694
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.09B | 0.02% | +0.9% |
| 2 | VANGUARD GROUP INC | $765.54M | 0.01% | New |
| 3 | FMR LLC | $706.76M | 0.04% | -16.3% |
| 4 | STATE STREET CORP | $378.67M | 0.01% | -1.4% |
| 5 | CITADEL ADVISORS LLC | $102.45M | 0.02% | -1.2% |
| 6 | Point72 Asset Management, L.P. | $43.57M | 0.06% | +1676.9% |
| 7 | MILLENNIUM MANAGEMENT LLC | $21.54M | 0.01% | +45.0% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of CYTK with a position worth $1.09B, representing 0.02% of their portfolio. In total, 7 institutional investors hold CYTK with a combined value of $3.11B.
In the most recent quarter, 1 fund opened a new position in CYTK. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $3.11B worth of CYTK stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $1.09B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CYTK, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CYTK positions.